1. Zang, Yong, Wang, Aiyuan, Zhang, Jianji, Chen, Yupeng, Zhang, Kai. 2024. Hypoxia promotes histone H3K9 lactylation to enhance LAMC2 transcription in esophageal squamous cell carcinoma. In iScience, 27, 110188. doi:10.1016/j.isci.2024.110188. https://pubmed.ncbi.nlm.nih.gov/38989468/
2. Cheng, Lulu, Li, Xiaofei, Dong, Wenhui, Yin, Jiajun, Guo, Lianyi. 2024. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway. In Journal of cancer research and clinical oncology, 150, 230. doi:10.1007/s00432-024-05720-7. https://pubmed.ncbi.nlm.nih.gov/38703300/
3. Ong, Khaa Hoo, Hsieh, Yao-Yu, Lai, Hong-Yue, Li, Chien-Feng, Kuo, Yu-Hsuan. 2023. LAMC2 is a potential prognostic biomarker for cholangiocarcinoma. In Oncology letters, 26, 533. doi:10.3892/ol.2023.14120. https://pubmed.ncbi.nlm.nih.gov/38020294/
4. Wang, Ding, Keyoumu, Kailibinuer, Yu, Rongji, Di, Xiaotang, Zhang, Shubing. 2024. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway. In Molecular medicine (Cambridge, Mass.), 30, 61. doi:10.1186/s10020-024-00827-6. https://pubmed.ncbi.nlm.nih.gov/38760717/
5. Cave, Donatella Delle, Buonaiuto, Silvia, Sainz, Bruno, De Luca, Annachiara, Lonardo, Enza. 2022. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. In Journal of experimental & clinical cancer research : CR, 41, 315. doi:10.1186/s13046-022-02516-w. https://pubmed.ncbi.nlm.nih.gov/36289544/
6. Garg, Manoj, Braunstein, Glenn, Koeffler, Harold Phillip. 2014. LAMC2 as a therapeutic target for cancers. In Expert opinion on therapeutic targets, 18, 979-82. doi:10.1517/14728222.2014.934814. https://pubmed.ncbi.nlm.nih.gov/24976367/
智鼠故事 
